CD8A and neoplasm: An unprecedented correlation exists between immune system activation and ATRA supplementation, while one of the immune-related mechanisms indicates that the benefits of ATRA treatment are mediated by cytotoxic CD8+ T cells, stimulated due to MHCI upregulation on tumor cells [42].